ANAB
ANAB
Positions held
Your positionsANAB isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · AnaptysBio (ANAB) Could Be 49% Undervalued On Its Royalty Story
2026-10-08 · AnaptysBio (ANAB) Stock Looks Undervalued Even After A 273% Rise
2026-09-26 · AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance
2026-09-26 · AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns?
2026-09-21 · AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
2026-09-21 · AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours
2026-09-21 · Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update
2026-09-14 · Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB)
2026-09-01 · Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-17 · GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control
2026-07-14 · What Makes AnaptysBio (ANAB) an Investment Bet?
Price (daily)
Full chart · RSI · MACD · patterns